What is HPV?
Human papillomavirus (HPV) is a group of viruses that are extremely common worldwide. HPV is mainly transmitted through sexual contact and most people are infected with HPV shortly after the onset of sexual activity. Human papillomavirus (HPV) infection is now a well-established cause of cervical cancer and there is growing evidence of HPV being a relevant factor in other ano genital cancers (anus, vulva, vagina and penis) as well as head and neck cancers.
There are more than 100 types of HPV identified .
High-risk HPV types can cause cancer.
- Atleast 16 kinds of highrisk HPV are recognized as the root cause of most cancer. 16, 18, 31, 33, 34, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68, and 70 types. HPV types 16 and 18 are responsible for about 70% of all cervical cancer cases worldwide
Low-risk HPV types do not cause cancer.
- Low-risk HPV types include types 6, 11, 42, 43, and 44.
- Some other disease may occur ,including genital warts 44.About 96,922 new cervical cancer cases are diagnosed annually in India (estimates for 2018).
- Cervical cancer ranks as the 2nd leading cause of female cancer in India.
- About 60,078 cervical cancer deaths occur annually in India (estimates for 2018).
- Cervical cancer is the 2 th most common female cancer in women aged 15 to 44 years in India
Available Treatment for HPV
Available cervical cancer control includes primary prevention (vaccination against HPV), secondary prevention (screening and treatment of pre-cancerous lesions), tertiary prevention (diagnosis and treatment of invasive cervical cancer) and palliative care.
About 96,922 new cervical cancer cases are diagnosed annually in India (estimates for 2018).
Prevalence of Sexually transmitted infections in different age groups of Women
Customer Testimonials
-
After two months of BASANT I finally tested hrHPV-negative for the first time in eight years. The support team’s check-ins kept me on track.
Kelly D., Chicago, USA -
Discharge and odour eased within 10 days, and my HPV-16 PCR was negative at 6 weeks.
Maria R., Phoenix, USA -
Long-standing BV cleared after one course. The instructions were clear and easy to follow.
Caroline S., Boston, USA -
One BASANT cycle moved my Pap result from LSIL to normal; mild itching on Night 2 faded quickly.
Jasmine L., Tampa, USA -
Recurrent azole-resistant Candida resolved in three weeks, and the CRM team replied promptly whenever I had questions.
Tonya P., Seattle, USA -
I never felt like I was doing this alone. The calm guidance from your team plus BASANT eased my Hpv journey.
Lindiwe M., Johannesburg, SA -
Minor dryness in Week 1 disappeared once, under medical guidance, I moistened the capsule before insertion; my HPV-18 test was negative 12 weeks later.
Nomusa K., Durban, SA -
Drug-resistant gonorrhoea culture turned negative after my BASANT course; symptoms settled faster than expected.
Thandi R., Cape Town, SA -
My HPV-59 finally cleared after 3 months with BASANT, and the team followed up right through my three-month review.
Renee T., Pretoria, SA -
Support sessions were unhurried and informative; HPV load dropped to undetectable by Week 10.
Megha S., Bengaluru, India -
Discomfort eased, pH normalised, and I feel more in control now. The team’s prompt support made this journey reassuring. Looking forward to my next HPV screen with confidence.
Lebo M., Gauteng, SA -
Mild cervical changes improved after one course, and every query I sent was answered within hours.
Sarah K., Dallas, USA
